Skip to main content

Point72 Asset Management, L.P.

Position in ADCT — ADC Therapeutics SA

CIK 1603466 STAMFORD, CT

Position in ADCT

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$12,682,983
-$5,018,615 QoQ
Shares Held
3,382,129
-32.6% QoQ
Ownership
2.66%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2022
5 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ADCT Over Time

Shares Held

Position Value (USD)

Derivatives in ADCT

reported options exposure · as of Mar 31, 2026
CallValue
$99,000
CallShares
26,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Point72 Asset Management, L.P. holds $418,627,713 across 21 Drug Manufacturers - Specialty & Generic names. ADCT ranks #8 (3.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 ADCT
ADC Therapeutics SA
This page
3,382,129 $12,682,983

All Filings in ADCT

Export CSV
7 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $99,000 26,400
2026-03-31 $12,682,983 3,382,129
2025-12-31 $17,701,598 5,014,617
2025-09-30 $32,542,604 8,135,651
2025-06-30 $20,806,603 7,763,658
2025-06-16 $26,470,216 7,831,425
2022-12-31 $2,705,280 704,500